Literature DB >> 3010940

Nature and properties of human platelet vasopressin receptors.

D Vittet, A Rondot, B Cantau, J M Launay, C Chevillard.   

Abstract

The binding of 3H-labelled [8-arginine]vasopressin to human platelets or crude platelet membranes was examined. Both preparations specifically bound [8-arginine]vasopressin. The binding increased linearly with protein concentration, it was temperature- and time-dependent, saturable and could be reversed to a large extent by EDTA (10 mM). In this latter case, addition of an excess of MgCl2 (20 mM) restored the initial level of binding. Intact platelets and membranes derived from these platelets presented a single population of binding sites with a dissociation constant (Kd) of 1.3 +/- 0.2 and 1.8 +/- 0.3 nM and a maximal binding capacity of 142 +/- 48 and 270 +/- 17 fmol/mg of protein, respectively. The Kd values of various analogues correlated well with those determined on rat liver membrane V1 vasopressin receptors but not with those determined on rat kidney membrane V2 receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010940      PMCID: PMC1153078          DOI: 10.1042/bj2330631

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Specific binding of (3H) lysine-vasopressin to pig kidney plasma membranes. Relationship of receptor occupancy to adenylate cyclase activation.

Authors:  J Bockaert; C Roy; R Rajerison; S Jard
Journal:  J Biol Chem       Date:  1973-09-10       Impact factor: 5.157

3.  Aggregation of human blood platelets by vasopressin.

Authors:  R J Haslam; G M Rosson
Journal:  Am J Physiol       Date:  1972-10

4.  Vasopressin and oxytocin in cerebrospinal fluid and plasma of conscious rabbits--response to dehydration and haemorrhage.

Authors:  R Landgraf; O Günther
Journal:  Biomed Biochim Acta       Date:  1983

5.  5-hydroxytryptamine releases adenosine 5'-triphosphate from nerve varicosities isolated from the myenteric plexus of guinea-pig ileum.

Authors:  M Al-Humayyd; T D White
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

6.  Some properties of the human platelet vasopressin receptor.

Authors:  M E Thomas; A H Osmani; M C Scrutton
Journal:  Thromb Res       Date:  1983-12-15       Impact factor: 3.944

7.  Vasopressin-induced activation of human blood platelets: prominent role of Mg2+.

Authors:  P Erne; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-03       Impact factor: 3.000

8.  Human platelet vasopressin receptors.

Authors:  W H Berrettini; R M Post; E K Worthington; J B Casper
Journal:  Life Sci       Date:  1982-02-01       Impact factor: 5.037

9.  Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1-receptors.

Authors:  M Vanderwel; D S Lum; R J Haslam
Journal:  FEBS Lett       Date:  1983-12-12       Impact factor: 4.124

10.  Phosphatidylinositol metabolism in rat hepatocytes stimulated by vasopressin.

Authors:  C J Kirk; R H Michell; D A Hems
Journal:  Biochem J       Date:  1981-01-15       Impact factor: 3.857

View more
  6 in total

1.  Autoradiographic analysis of vasoactive neuropeptide uptake by rabbit megakaryocytes and platelets.

Authors:  T Daimon
Journal:  J Anat       Date:  1991-06       Impact factor: 2.610

2.  In vitro enhancement of human platelet aggregation by somatostatin.

Authors:  P P Gazzaniga; G Di Macco; R La Mancusa; A Oddi; G Pappalardo; F M Pulcinelli; D Reggio
Journal:  Experientia       Date:  1988-10-15

3.  Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

Authors:  C Serradeil-Le Gal; J Wagnon; C Garcia; C Lacour; P Guiraudou; B Christophe; G Villanova; D Nisato; J P Maffrand; G Le Fur
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus.

Authors:  N Knoers; P M Janssens; J Goertz; L A Monnens
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

5.  Human platelet fraction arginine-vasopressin. Potential physiological role.

Authors:  D G Bichet; M F Arthus; J N Barjon; M Lonergan; C Kortas
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

Review 6.  Platelets as a model for neurones?

Authors:  M Da Prada; A M Cesura; J M Launay; J G Richards
Journal:  Experientia       Date:  1988-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.